neurological disorders

A two year clinical, immunological and gut-brain-axis prospective study to predict treatment response to cladribine tablets in relapsing-remitting multiple sclerosis

Study Overview This prospective study investigated the effects of cladribine tablets on individuals diagnosed with relapsing-remitting multiple sclerosis (RRMS), focusing

A two year clinical, immunological and gut-brain-axis prospective study to predict treatment response to cladribine tablets in relapsing-remitting multiple sclerosis Read Post »

Scroll to Top